UNION CITY, Calif., Jan. 30, 2014 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the third fiscal quarter ended December 31, 2013.
Quarterly highlights include:
•Service revenues from Abaxis Veterinary Reference Laboratories (AVRL) of $2.5 million, up 80% over last year’s comparable quarter.
Help employers find you! Check out all the jobs and post your resume.